Falcon Point Capital’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-33,379	Closed	-$501K	–	118
2017 Q1	$501K	Buy	+33,379	New	+$501K	0.07%	100
2016 Q1	–	Sell	-10,897	Closed	-$291K	–	125
2015 Q4	$291K	Buy	+10,897	New	+$291K	0.06%	102